Submit Deal

VELOXIS PHARMACEUTICALS

Summary

Veloxis Pharmaceuticals develops improved versions of difficult-to-formulate drugs with its proprietary drug formulation technology.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 1.02 B

Avg. Deal Size£ 1.02 B

Market Context

Senior Management

Sort

Target: VELOXIS PHARMACEUTICALS

Bidder: ASAHI KASEI CORPORATION

14 Service Providers

37 Dealmakers

£ 1.02 B

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy